What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?

BMC Gastroenterology

Volumn 9, Issue , 2009, Pages

  Tarantino, Giovanni ^a   Citro, Vincenzo ^b   Conca, Paolo ^a   Riccio, Antonio ^a   Tarantino, Marianna ^a   Capone, Domenico ^a   Cirillo, Michele ^a   Lobello, Roberto ^a   Iaccarino, Vittorio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ASL Sa 1   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL ABUSE; ARTICLE; ASCITES; CORRELATION ANALYSIS; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FATTY LIVER; FEMALE; FLOW RATE; HEPATIC ENCEPHALOPATHY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREVALENCE; SPLENORENAL SHUNT; AGED; CLINICAL TRIAL; COLLATERAL CIRCULATION; COMPARATIVE STUDY; DOPPLER FLOWMETRY; ECHOGRAPHY; FOLLOW UP; KIDNEY CIRCULATION; KIDNEY VEIN; METHODOLOGY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PORTAL VEIN; PROGNOSIS; RETROSPECTIVE STUDY;

AGED; COLLATERAL CIRCULATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; MALE; PORTAL SYSTEM; PORTAL VEIN; PREVALENCE; PROGNOSIS; RENAL CIRCULATION; RENAL VEINS; RETROSPECTIVE STUDIES; SPLENORENAL SHUNT, SURGICAL; ULTRASONOGRAPHY, DOPPLER;

EID: 71549119489     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-9-89     Document Type: Article

References (50)

1. Blei AT. Portal hypertension and its complications. Curr Opin Gastroenterol 2007, 23:275-282. 10.1097/MOG.0b013e3280b0841f, 17414843.
2. Fernandez M, Mejias M, Garcia-Pras E, Mendez R, Garcia-Pagan JC, Bosch J. Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats. Hepatology 2007, 46:1208-1217. 10.1002/hep.21785, 17654489.
3. Ripoll C, Groszmann RJ, Garcia-Tsao G, Bosch J, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, . Portal Hypertension Collaborative Group Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol 2009, 50:923-928. 10.1016/j.jhep.2009.01.014, 19303163.
4. Del Piccolo F, Sacerdoti D, Amodio P, Bombonato G, Bolognesi M, Mapelli D, Gatta A. Central nervous system alterations in liver cirrhosis: the role of portal-systemic shunt and portal hypoperfusion. Metab Brain Dis 2002, 17:347-358. 10.1023/A:1021914003218, 12602511.
5. De Franchis R, Salerno F. Pathogenesis of ascites and predictors of resistance to therapy. J Gastroenterol Hepatol 2002, 17:S242-247. 10.1046/j.1440-1746.17.s3.7.x, 12472943.
6. Primignani M, Carpinelli L, Preatoni P, Battaglia G, Carta A, Prada A, Cestari R, Angeli P, Gatta A, Rossi A, Spinzi G, De Franchis R. Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 2000, 119:181-187. 10.1053/gast.2000.8555, 10889167.
7. Merli M, Nicolini G, Angeloni S, Gentili F, Attili AF, Riggio O. The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am J Gastroenterol 2004, 99:1959-1965. 10.1111/j.1572-0241.2004.40246.x, 15447756.
8. Mostbeck GH, Wittich GR, Herold C, Vergesslich KA, Walter RM, Frotz S, Sommer G. Hemodynamic significance of the paraumbilical vein in portal hypertension: assessment with duplex US. Radiology 1989, 170:339-342.
9. Zardi EM, Uwechie V, Caccavo D, Pellegrino NM, Cacciapaglia F, Di Matteo F, Dobrina A, Laghi V, Afeltra A. Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance. J Gastroenterol 2009, 44:76-83. 10.1007/s00535-008-2279-1, 19159076.
10. von Herbay A, Frieling T, Haussinger D. Color Doppler sonographic evaluation of spontaneous portosystemic shunts and inversion of portal venous flow in patients with cirrhosis. J Clin Ultrasound 2000, 28:332-339. 10.1002/1097-0096(200009)28:7<332::AID-JCU3>3.0.CO;2-9, 10934332.
11. Bresci G, Gambardella L, Parisi G, Federici G, Bertini M, Rindi G, Metrangolo S, Tumino E, Bertoni M, Cagno MC, Capria A. Colonic disease in cirrhotic patients with portal hypertension: an endoscopic and clinical evaluation. J Clin Gastroenterol 1998, 26:222-227. 10.1097/00004836-199804000-00016, 9600375.
12. Riggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, Nicolao F, Angeloni S, Masini A, Ridola L, Attili AF, Merli M. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology 2005, 42:1158-1165. 10.1002/hep.20905, 16250033.
13. Kim M, Mitchell DG, Ito K. Portosystemic collaterals of the upper abdomen: review of anatomy and demonstration on MR imaging. Abdom Imaging 2000, 25:462-470. 10.1007/s002610000014, 10931979.
14. Kashiwagi T, Kimura K, Kozuka T, Sato N, Kamada T, Mitsutani N, Koizumi T. Portosystemic collaterals in portal hypertension: visualization by using blood-pool SPECT imaging. Am J Roentgenol 1989, 153:281-285.
15. Azuma M, Kashiwagi T, Nagasawa M, Ito Y, Naito M, Ishibashi K, Katayama K. Evaluation of portosystemic collaterals by SPECT imaging after endoscopic variceal sclerotherapy: usefulness for predicting recurrence. J Nucl Med 2000, 41:600-604.
16. Nakamura R, Hirose A, Nakasato T, Yoshioka K, Sasaki M, Tamakawa Y, Sasaki A. Detection of paraumbilical or splenorenal shunts by intra-arterial-DSA in bleeding varices: another risk factor?. Radiat Med 1998, 16:341-345.
17. Kashiwagi T, Kimura K, Suematsu T, Shichiri M, Kamada T, Abe H. Dynamic studies on portal haemodynamics by scintiphotosplenoportography: flow patterns of portal circulation. Gut 1980, 21:57-62. 10.1136/gut.21.1.57, 1419575, 7189169.
18. Smith Laing G, Camilo ME, Dick R, Sherlock S. Percutaneous transhepatic portography in the assessment of portal hypertension: clinical correlation and comparison of radiographic techniques. Gastroenterology 1980, 78:197-205.
19. Martínez-Noguera A, Montserrat E, Torrubia S, Villalba J. Doppler in hepatic cirrhosis and chronic hepatitis. Semin Ultrasound CT MR 2002, 23:19-36. 10.1016/S0887-2171(02)90027-2, 11866220.
20. Robinson KA, Middleton WD, Al-Sukaiti R, Teefey SA, Dahiya N. Doppler sonography of portal hypertension. Ultrasound Q 2009, 25:3-13. 10.1097/RUQ.0b013e31819c8685, 19276931.
21. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with Mmirroring R imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003, 229:409-414. 10.1148/radiol.2292021128, 12970464.
22. Perisic M, Ilic-Mostic T, Stojkovic M, Culafic D, Sarenac R. Doppler hemodynamic study in portal hypertension and hepatic encephalopathy. Hepatogastroenterology 2005, 52:156-160.
23. Yin XY, Lu MD, Huang JF, Xie XY, Liang LJ. Color Doppler velocity profile assessment of portal hemodynamics in cirrhotic patients with portal hypertension: correlation with esophageal variceal bleeding. J Clin Ultrasound 2001, 29:7-13. 10.1002/1097-0096(200101)29:1<7::AID-JCU2>3.0.CO;2-V, 11180179.
24. Luo JC, Hwang SJ, Chang FY, Chu CW, Lai CR, Wang YJ, Lee PC, Tsay SH, Lee SD. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C. Hepatogastroenterology 2002, 49:478-481.
25. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981, 27:213-218. 10.1016/S0016-5107(81)73224-3, 6975734.
26. Gooding GA, Cummings SR. Sonographic detection of ascites in liver disease. J Ultrasound Med 1984, 3:69-72.
27. Conn HO, Liebertahl MM. The hepatic coma syndromes and lactulose. 1979, 1-121. Williams and Wilkins, Baltimore.
28. Citro V, Milan G, Tripodi FS, Gennari A, Sorrentino P, Gallotta G, Postiglione A, Tarantino G. Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. J Gastroenterol 2007, 42:79-82. 10.1007/s00535-006-1978-8, 17322997.
29. Tarantino G, Gentile A, Capone D, Basile V, Tarantino M, Di Minno MN, Cuocolo A, Conca P. Does protracted antiviral therapy impact on HCV-related liver cirrhosis progression?. World J Gastroenterol 2007, 13:4903-4908.
30. Planas R, Balleste B, Alvarez MA, Rivera M, Montoliu S, Galeras JA, Santos J, Coll S, Morillas RM, Solà R. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 2004, 40:823-830. 10.1016/j.jhep.2004.01.005, 15094231.
31. Von Herbay A, Frieling T, Haussinger D. Color Doppler sonographic evaluation of spontaneous portosystemic shunts and inversion of portal venous flow in patients with cirrhosis. J Clin Ultrasound 2000, 28:332-339. 10.1002/1097-0096(200009)28:7<332::AID-JCU3>3.0.CO;2-9, 10934332.
32. Santambrogio R, Opocher E, Costa M, Bruno S, Ceretti AP, Spina GP. Natural history of a randomized trial comparing distal spleno-renal shunt with endoscopic sclerotherapy in the prevention of variceal rebleeding: a lesson from the past. World J Gastroenterol 2006, 12:6331-6338.
33. Khan S, Tudur Smith C, Williamson P, Sutton R. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev 2006, 4:CD000553.
34. Braun MM, Bar-Nathan N, Shaharabani E, Aizner S, Tur-Kaspa R, Belenky A, Mor E, Ben-Ari ZZ. Postshunt hepatic encephalopathy in liver transplant recipients. Transplantation 2009, 87:734-739. 10.1097/TP.0b013e318196340d, 19295319.
35. Nakano T, Lai CY, Goto S, Hsu LW, Huang TL, Chen TY, Tsang LC, Chen CL, Cheng YF. Significance of portosystemic shunt on graft survival in liver transplantation: a rat model. Transplant Proc 2008, 40:2515-2516. 10.1016/j.transproceed.2008.07.056, 18929784.
36. Sato Y, Mitsuma C, Iwaya A, Kurosaki I, Shirai Y, Hatakeyama K. Resection of spleno-renal shunt resulting in enhanced liver volume in a patient with congenital portosystemic shunt concomitant with early gastric cancer. Review of Japanese cases. Dig Surg 2001, 18:74-78. 10.1159/000050102, 11244265.
37. Král V, Klein J, Havlik R, Vomácka J, Utikal P, Vrba R. Peripheral portosystemic shunt and its selectivity changes measured on duplex ultrasound. Hepatogastroenterology 2005, 52:149-151.
38. Salerno F, Cammà C, Enea M, Rössle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data. Gastroenterology 2007, 133:825-834. 10.1053/j.gastro.2007.06.020, 17678653.
39. Albillos A, Bañares R, González M, Catalina MV, Molinero LM. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol 2005, 43:990-996. 10.1016/j.jhep.2005.06.005, 16139922.
40. Umemura T, Ichijo T, Yoshizawa K, Tanaka E, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol 2009, 44:102-107. 10.1007/s00535-008-2251-0, 19148802.
41. Schoenleber SJ, Kurtz DM, Talwalkar JA, Roberts LR, Gores GJ. Prognostic role of vascular endothelial growth factor in hepatocellular carcinoma: systematic review and meta-analysis. Br J Cancer 2009, 100:1385-1392. 10.1038/sj.bjc.6605017, 19401698.
42. Polesel J, Zucchetto A, Montella M, Dal Maso L, Crispo A, La Vecchia C, Serraino D, Franceschi S, Talamini R. The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma. Ann Oncol 2009, 20:353-357. 10.1093/annonc/mdn565, 18723550.
43. Tarantino G, Conca P, Pasanisi F, Ariello M, Mastrolia M, Arena A, Tarantino M, Scopacasa F, Vecchione R. Could inflammatory markers help diagnose nonalcoholic steatohepatitis?. Eur J Gastroenterol Hepato 2009, 21:504-511.
44. Yamamoto C, Yagi S, Hori T, Iida T, Taniguchi K, Isaji S, Uemoto S. Significance of Portal Venous VEGF During Liver Regeneration After Hepatectomy. J Surg Res 2008,
45. Wattanasirichaigoon S, Gordon FD, Resnick RH. Hyperdynamic circulation in portal hypertension: a comparative model of arterio-venous fistula. Med Hypotheses 2000, 55:77-87. 10.1054/mehy.1999.1034, 11021333.
46. Sho E, Komatsu M, Sho M, Nanjo H, Singh TM, Xu C, Masuda H, Zarins CK. High flow drives vascular endothelial cell proliferation during flow-induced arterial remodeling associated with the expression of vascular endothelial growth factor. Exp Mol Pathol 2003, 75:1-11. 10.1016/S0014-4800(03)00032-7, 12834620.
47. Takashi M, Igarashi M, Hino S, Takayasu K, Goto N, Musha H, Ohnishi K, Okuda K. Portal hemodynamics in chronic portal-systemic encephalopathy. Angiographic study in seven cases. J Hepatol 1985, 1:467-476. 10.1016/S0168-8278(85)80745-5, 4056350.
48. Kato T, Uematsu T, Nishigaki Y, Sugihara J, Tomita E, Moriwaki H. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis. Int Med 2001, 40:677-678.
49. Kiyosawa K. Trend of liver cirrhosis as precancerous lesions. Hepatol Res 2002, 24:40-45.
50. Hamza SM, Kaufman S. Role of spleen in integrated control of splanchnic vascular tone: physiology and pathophysiology. Can J Physiol Pharmacol 2009, 87:1-7. 10.1139/Y08-103, 19142210.